In the evolving landscape of Parkinson’s disease (PD) therapies, device-aided interventions have emerged as crucial tools in managing symptoms beyond the capabilities of pharmacological treatments...
HIV-1 Signalling Remodels Nuclear Pores to Licence Infection in Resting T Cells Human Immunodeficiency Virus type 1 (HIV-1) continues to challenge the scientific and medical...
In a groundbreaking new study that could reshape the landscape of cancer immunotherapy, researchers have discovered a novel mechanism to enhance T-cell activation by targeting...
A Comprehensive Examination of Aluminium Adjuvants in Vaccines Reveals No Causal Link to Serious Health Conditions In an extensive systematic review published today in The...
In a groundbreaking clinical trial that may transform the management of peanut allergies among young children, researchers from Karolinska Institutet have demonstrated the safety and...
Sophia Antipolis, France – May 7, 2026. In a landmark report published today in the European Heart Journal, leading cardiology experts from across Europe have...
A groundbreaking study led by researchers at the University of Cambridge has revealed a significant shift in mental health clinicians’ attitudes toward understanding anxiety disorders....
In a groundbreaking study published in npj Parkinson’s Disease, a team of researchers led by Sun, X., An, Z., and Wang, S. has unveiled compelling...
In an era where the SARS-CoV-2 virus continuously evolves, understanding the nuances of its spike protein’s conformation is pivotal for staying ahead in therapeutic development....
In a groundbreaking new study published in npj Parkinson’s Disease, researchers have unveiled a compelling connection between allergic diseases and the risk of Parkinson’s disease...
A groundbreaking study published in Nature underlines a transformative insight into the human proteome, revealing a landscape enriched by microproteins and peptideins originating from non-canonical...
In a groundbreaking clinical milestone, the novel targeted RAS inhibitor daraxonrasib has demonstrated both safety and promising efficacy in a phase 1/2 trial involving patients...
The upcoming ASCO 2026 Annual Meeting, scheduled to take place in Chicago from May 29 to June 2, promises to be a pivotal event in...
In a groundbreaking development that promises to reshape the therapeutic landscape for colorectal cancer, researchers at the Icahn School of Medicine at Mount Sinai, in...
Electronic nematicity, a fascinating phase found in a variety of crystalline solids, has been thrust into the spotlight of condensed matter physics for its crucial...
